haloperidol decanoate: Clinical Trials

3 trials of haloperidol decanoate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Terminated 1

Follow haloperidol decanoate: new trials by email Literature Review of haloperidol decanoate trials Research Report on haloperidol decanoate

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Comparison of Long-acting Injectable Medications for Schizophrenia
haloperidol decanoate, paliperidone palmitate - Schizophrenia, Schizoaffective Disorder
Phase 4CompletedNew York State Psychiatric Institute3112011-03-012016-10-21
Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol
Haloperidol decanoate, Placebo - Subsyndromal Delirium
Phase 4CompletedNortheastern University682010-09-012017-04-14
Lamictal TM, Haloperidol Decanoate in Schizophrenia
Lamictal TM, Haloperidol Decanoate - Schizophrenia
Phase 4TerminatedCentral Mental Clinic for Outpatients of Baku City3352005-01-012009-07-28

Conditions studied

Schizophrenia (2)  ·  Delirium (1)  ·  Psychotic Disorders (1)

Sponsors

Central Mental Clinic for Outpatients of Baku City (1)  ·  New York State Psychiatric Institute (1)  ·  Northeastern University (1)

Countries

United States (2)  ·  Azerbaijan (1)

Top investigators

Greg Schumaker, MD (1)  ·  John W Devlin, PharmD (1)  ·  Joseph P McEvoy, MD (1)  ·  Nadir A Aliyev, PHD, MD (1)  ·  Scott Stroup, MD, MPH (1)

Results publications

PMID 24846035, PMID 27247177, PMID 30549494

NIH funding

R01MH081107 (1), R15AG034915 (1)